Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 52, 2017 - Issue 8
Submit an article Journal homepage
476
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Smoking, alcohol and family history of cancer as risk factors for small intestinal neuroendocrine tumors: a systematic review and meta-analysis

Sven-Petter HaugvikDepartment of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway; ;Department of Surgery, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway; Correspondence[email protected]
,
Ibrahim Basim IbrahimInstitute of Clinical Medicine, University of Oslo, Oslo, Norway;
,
Per HedenströmUnit of Gastroenterology, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden;
,
Roberto ValenteDigestive and Liver Disease Unit, II Medical School, University ‘La Sapienza’, S. Andrea Hospital, Rome, Italy;
,
Alastair J HayesDepartment of General Surgery, Royal Infirmary of Edinburgh, Edinburgh, Scotland;
,
Darko SiukaDepartment of Gastroenterology, University Medical Centre Ljubljana, Ljubljana, Slovenia
,
Ivar Prydz GladhaugDepartment of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway; ;Institute of Clinical Medicine, University of Oslo, Oslo, Norway;
&
Gabriele CapursoDigestive and Liver Disease Unit, II Medical School, University ‘La Sapienza’, S. Andrea Hospital, Rome, Italy;
show all
Pages 797-802 | Received 02 Feb 2017, Accepted 18 Mar 2017, Published online: 10 Apr 2017

References

  • Hauso O, Gustafsson BI, Kidd M, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer. 2008;113:2655–2664.
  • Scherubl H, Jensen RT, Cadiot G, et al. Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management. World J Gastrointest Endosc. 2010;2:325–334.
  • Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61–72.
  • Boyar CR, Aagnes B, Thiis-Evensen E, et al. Trends in incidence of neuroendocrine neoplasms in Norway: a report of 16,075 cases from 1993 through 2010. Neuroendocrinology. 2017;104:1–10.
  • Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–535.
  • von Roon AC, Reese G, Teare J, et al. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum. 2007;50:839–855.
  • Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006;42:216–227.
  • Tsong WH, Koh WP, Yuan JM, et al. Cigarettes and alcohol in relation to colorectal cancer: the Singapore Chinese Health Study. Br J Cancer. 2007;96:821–827.
  • Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376:1741–1750.
  • Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev. 1994;3:205–207.
  • Cross AJ, Hollenbeck AR, Park Y. A large prospective study of risk factors for adenocarcinomas and malignant carcinoid tumors of the small intestine. Cancer Causes Control. 2013;24:1737–1746.
  • Hassan MM, Phan A, Li D, et al. Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study. Cancer Epidemiol Biomarkers Prev. 2008;17:959–965.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 200;21:1539–1558.
  • Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
  • Hassan MM, Phan A, Li D, et al. Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study. Int J Cancer. 2008;123:867–873.
  • Kaerlev L, Teglbjaerg PS, Sabroe S, et al. The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case-control study. Cancer Causes Control. 2002;13:27–34.
  • Kharazmi E, Pukkala E, Sundquist K, et al. Familial risk of small intestinal carcinoid and adenocarcinoma. Clin Gastroenterol Hepatol. 2013;11:944–949.
  • Rinzivillo M, Capurso G, Campana D, et al. Risk and protective factors for small intestine neuroendocrine tumors: a prospective case-control study. Neuroendocrinology. 2016;103:531–537.
  • Leoncini E, Carioli G, La VC, et al. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol. 2016;27:68–81.
  • Merola E, Rinzivillo M, Cicchese N, et al. Digestive neuroendocrine neoplasms: a 2016 overview. Dig Liver Dis. 2016;48:829–835.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.